Heliospectra: Commercial expansion with a ready product portfolio – Set for 2025 - Redeye

Redeye updated its estimates and fair value range following Heliospectra’s Q4 2024 report and the fully secured rights issue of SEK 25.6m, expected to be completed by the end of Q1. Although the Q4 report was softer than expected, the fundamentals are in place for accelerated growth. With strengthened financials, expanded commercial efforts, and ongoing product innovation, Heliospectra is well-positioned to seize market opportunities and drive increased growth in 2025

Länk till analysen i sin helhet: https://www.redeye.se/research/1086132/heliospectra-commercial-expansion-with-a-ready-product-portfolio-set-for-2025?utm_source=finwire&utm_medium=RSS